ArticlePolymers2025
Preliminary Study on the Development of a Biodegradable Functional Nasal Packing Material.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioprinting in Tissue Repair and Its ENT Applications.Polymers · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFunctional endoscopic sinus surgery is commonly performed to treat paranasal sinus diseases, often necessitating nasal packing to control bleeding and aid healing. However, current materials can cause discomfort or lack adequate antibacterial properties. This study aimed to develop a biodegradable, biocompatible nasal packing material by combining polyvinyl alcohol (PVA) and carbon dots (CDs), and to evaluate its antibacterial activity and tissue compatibility. MATERIALS AND
methodsElectrospun nanofiber membranes were fabricated using PVA and biomass-derived CDs. Antibacterial efficacy of nasal packing variants (PVA, PVA-chitosan [CS], PVA-CS-CDs-1 mL, and PVA-CS-CDs-2 mL) was assessed using the Kirby-Bauer disk diffusion method against
resultsAll materials demonstrated antibacterial activity, with PVA-CS-CDs-2 mL showing the largest inhibition zones. Histological examination revealed minimal epithelial damage and no inflammation, with PVA-CS-CDs-2 mL yielding the most favorable tissue response.
conclusionThe PVA-CS-CDs composite demonstrates potential as a biocompatible, antibacterial nasal packing material. Further studies are warranted to validate its long-term clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.